Maravai LifeSciences: Q3 Earnings Insights

Maravai LifeSciences MRVI reported its Q3 earnings results on Tuesday, November 7, 2023 at 04:05 PM.

Here's what investors need to know about the announcement.

Maravai LifeSciences missed estimated earnings by 200.0%, reporting an EPS of $-0.01 versus an estimate of $0.01.

Revenue was down $124.40 million from the same period last year.

Last quarter the company missed on EPS by $0.01 which was followed by a 0.73% increase in the share price the next day.

Here's a look at Maravai LifeSciences's past performance:

Quarter	Q2 2023	Q1 2023	Q4 2022	Q3 2022
EPS Estimate	0.01	0.04	0.34	0.33
EPS Actual	0	0.03	0.35	0.37
Revenue Estimate	70.30M	79.72M	204.93M	195.10M
Revenue Actual	68.91M	79.03M	204.71M	191.26M

To track all earnings releases for Maravai LifeSciences visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.